Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists
Dale A. Rudolph(Janssen (United States)), Michael A. Letavic(Janssen (United States)), Michael K. Ameriks(Janssen (United States)), Pascal Bonaventure(Janssen (United States)), Nicholas I. Carruthers(Io Therapeutics (United States)), Hong Ao(Janssen (United States)), Anindya Bhattacharya(University of York), Meri De Angelis(Helmholtz Zentrum München), Christa C. Chrovian(Janssen (United States)), Jason C. Rech(Janssen (United States)), Brian Lord(Janssen (United States)), Qi Wang(Hebei Medical University), Ana B. Antón, José Ignacio Andrés, Jesús Alcázar(Janssen (Belgium))
Cited by 33
Related Papers
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585
Heritability and genomics of gene expression in peripheral blood
|Nature Genetics|2014|424
Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene
|Journal of Biological Chemistry|1998|412
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408